Acadian Asset Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,829
| Closed | – | – | 1863 |
|
|
2024
Q4 | $0 | Hold |
1,829
| – | – | ﹤0.01% | 2274 |
|
|
2024
Q3 | $2K | Hold |
1,829
| – | – | ﹤0.01% | 2045 |
|
|
2024
Q2 | $13K | Sell |
1,829
-120
| -6% | -$853 | ﹤0.01% | 1694 |
|
|
2024
Q1 | $17K | Sell |
1,949
-1,690
| -46% | -$14.7K | ﹤0.01% | 1499 |
|
|
2023
Q4 | $38K | Hold |
3,639
| – | – | ﹤0.01% | 1494 |
|
|
2023
Q3 | $21K | Sell |
3,639
-1,759
| -33% | -$10.2K | ﹤0.01% | 1542 |
|
|
2023
Q2 | $36K | Sell |
5,398
-2,883
| -35% | -$19.2K | ﹤0.01% | 1567 |
|
|
2023
Q1 | $128K | Sell |
8,281
-2,824
| -25% | -$43.7K | ﹤0.01% | 1345 |
|
|
2022
Q4 | $220K | Buy |
11,105
+1,437
| +15% | +$28.5K | ﹤0.01% | 1262 |
|
|
2022
Q3 | $171K | Buy |
9,668
+6,329
| +190% | +$112K | ﹤0.01% | 1251 |
|
|
2022
Q2 | $74K | Buy |
+3,339
| New | +$74K | ﹤0.01% | 1420 |
|